BLT 5.77% 5.5¢ benitec biopharma limited

Hep B is the Holy Grail of gene therapy targets. A deal like...

  1. 871 Posts.
    lightbulb Created with Sketch. 60
    Hep B is the Holy Grail of gene therapy targets. A deal like this would be worth billions on paper in potential milestones and royalties. The upfront payment would be more than the current value of the company! Bring it on!
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.